Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Glaukos Corp
(NY:
GKOS
)
128.47
+1.92 (+1.52%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Glaukos Corp
< Previous
1
2
3
4
5
6
7
8
Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via
Benzinga
Where Glaukos Stands With Analysts
December 12, 2022
Via
Benzinga
Glaukos Announces Participation in the Stephens Annual Investment Conference
November 07, 2022
From
Glaukos Corporation
Via
Business Wire
What 4 Analyst Ratings Have To Say About Glaukos
November 03, 2022
Analysts have provided the following ratings for Glaukos (NYSE:GKOS) within the last quarter:
Via
Benzinga
Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock
October 04, 2022
Via
Benzinga
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
November 04, 2022
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Glaukos Corporation Announces Third Quarter 2022 Financial Results
November 02, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2
October 12, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate
September 07, 2022
Via
Benzinga
Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment
August 24, 2022
Via
Benzinga
Glaukos Receives FDA 510(k) Clearance For iStent infinite
August 03, 2022
The U.S.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting
September 28, 2022
From
Glaukos Corporation
Via
Business Wire
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Via
Benzinga
Dow Jumps 450 Points; UiPath Shares Slide
September 07, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday.
Via
Benzinga
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
September 08, 2022
Gainers
Via
Benzinga
Dow Up 249 Points, Nasdaq Set To Snap Skid
September 07, 2022
Stocks are charging higher this afternoon, though investors are still awaiting the release of the Federal Reserve's Beige Book.
Via
Talk Markets
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
September 07, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
Via
Benzinga
Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday
September 07, 2022
Via
Benzinga
What's Going On With Glaukos Shares?
September 07, 2022
Glaukos Corp (NYSE: GKOS) shares are trading higher by 1.87% to $49.00 Wednesday morning after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved...
Via
Benzinga
Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles
September 07, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide
September 06, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Participation in the Wells Fargo Healthcare Conference
August 24, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating
August 16, 2022
On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before.
Via
Investor's Business Daily
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 03, 2022
Via
Benzinga
Glaukos: Q2 Earnings Insights
August 03, 2022
Glaukos (NYSE:GKOS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos missed estimated earnings by...
Via
Benzinga
Glaukos Announces FDA 510(k) Clearance of iStent infinite®
August 03, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Corporation Announces Second Quarter 2022 Financial Results
August 03, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3
July 13, 2022
From
Glaukos Corporation
Via
Business Wire
The 6 Most Aggressive Growth Stocks to Buy in July
July 12, 2022
These are the 6 most aggressive growth stocks to buy in July. They reflect huge potential growth in their sales and/or their earnings.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.